DrugPatentWatch Database Preview
Mitsubishi Tanabe Company Profile
What is the competitive landscape for MITSUBISHI TANABE, and when can generic versions of MITSUBISHI TANABE drugs launch?
MITSUBISHI TANABE has one approved drug.
There is one US patent protecting MITSUBISHI TANABE drugs.
There are seven patent family members on MITSUBISHI TANABE drugs in six countries.
Summary for Mitsubishi Tanabe
| International Patents: | 7 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Mitsubishi Tanabe: | See patent lawsuits for Mitsubishi Tanabe |
Drugs and US Patents for Mitsubishi Tanabe
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mitsubishi Tanabe | RADICAVA | edaravone | SOLUTION;INTRAVENOUS | 209176-001 | May 5, 2017 | RX | Yes | Yes | 6,933,310 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Mitsubishi Tanabe | RADICAVA | edaravone | SOLUTION;INTRAVENOUS | 209176-002 | Nov 15, 2018 | RX | Yes | Yes | 6,933,310 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Mitsubishi Tanabe | RADICAVA | edaravone | SOLUTION;INTRAVENOUS | 209176-001 | May 5, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Mitsubishi Tanabe Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 0234264 | ➤ Try a Free Trial |
| Austria | 303808 | ➤ Try a Free Trial |
| European Patent Office | 1405637 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
